Investment Opportunity

Partner in Healthcare's Revenue Revolution

Join Revena Health in transforming how hospitals recover lost revenue. A unique equity opportunity in Africa's emerging health-tech market.

Investment Highlights

A compelling opportunity with clear value proposition and strategic upside

40% Equity Available

Direct share purchase from founders with significant ownership stake

97% Recovery Rate

Proven methodology validated through real hospital pilots

18-30% Commission

Value-based revenue model with high margins on recovered claims

Regional Expansion

Kenya launch with phased expansion across emerging markets

Equity & Ownership Structure

Investors acquire 40% equity through direct share purchase from founders, with comprehensive governance rights and strategic influence.

Direct Share Purchase

10% equity from each of four founders = 40% total stake

Founder Continuity

Founders retain 15% each with operational control continuity

Protected Investment

Comprehensive investor rights with anti-dilution protection

Investor Rights & Governance

Board representation
Reserved matters protection
Financial reporting rights
Audit rights
Information rights
Preference on exit
Anti-dilution protection
Right of first refusal

Use of Equity Funding

Capital will be strategically deployed to accelerate market entry and scale operations

Market Entry & Sales35%
Technology & Infrastructure25%
Team & Hiring20%
Legal & Compliance10%
Working Capital10%

Investor Inquiry

Express your interest and our team will reach out to discuss the opportunity in detail

By submitting this form, you agree to be contacted by our investor relations team. Your information will be kept confidential.

Investment Timeline

A structured approach to partnership and value creation

Phase 1

Due Diligence

Comprehensive review of technology, financials, and market opportunity

2-4 weeks
Phase 2

Term Sheet & Negotiation

Agreement on valuation, equity structure, and governance terms

2-3 weeks
Phase 3

Legal Documentation

Share purchase agreement, shareholders agreement, and closing

3-4 weeks
Phase 4

Deployment & Scale

Capital deployment, market entry acceleration, and growth execution

Ongoing